论文部分内容阅读
本文报道了我院第一附属医院血液病研究室用半合成三尖杉酯碱治疗20例非淋巴细胞性急性白血病的情况。20例患者经临床、血象及骨髓证实诊断。其中急粒白17例,红白血病、粒单白及骨髓纤维化症急粒变各1例。初治19例,复治1例。诱导治疗方法为半合成三尖杉酯碱8～20毫克,静脉滴注,每日一次,5～7天为一疗程。凡完成两个疗程以上者列入本组统计。维持治疗剂量同前,每1～3月治疗1～2疗程。
This article reports the first Affiliated Hospital of Hematology Laboratory with semi-synthetic harringtonine treatment of 20 cases of non-lymphocytic acute leukemia. Twenty patients were diagnosed clinically, hemogram and bone marrow. Of which 18 cases of acute white, erythroleukemia, granulosa and myelofibrosis acute granuloma in 1 case. Initial treatment in 19 cases, retreatment in 1 case. Induction therapy for the semi-synthetic harringtonine 8 to 20 mg intravenously, once daily, 5 to 7 days for a course of treatment. Those who completed more than two courses included in this group statistics. To maintain the same dose of treatment, 1 to 3 months for treatment of 1 to 2 courses.